These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11716518)

  • 1. Low M(r) protein tyrosine phosphatase inhibits growth and migration of vascular smooth muscle cells induced by platelet-derived growth factor.
    Shimizu H; Shiota M; Yamada N; Miyazaki K; Ishida N; Kim S; Miyazaki H
    Biochem Biophys Res Commun; 2001 Nov; 289(2):602-7. PubMed ID: 11716518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis.
    Kappert K; Sparwel J; Sandin A; Seiler A; Siebolts U; Leppänen O; Rosenkranz S; Ostman A
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2644-51. PubMed ID: 16990553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the role of low molecular weight phosphotyrosine phosphatase (LMW-PTP) on platelet-derived growth factor receptor (PDGF-r) signaling. LMW-PTP controls PDGF-r kinase activity through TYR-857 dephosphorylation.
    Chiarugi P; Cirri P; Taddei ML; Giannoni E; Fiaschi T; Buricchi F; Camici G; Raugei G; Ramponi G
    J Biol Chem; 2002 Oct; 277(40):37331-8. PubMed ID: 12149261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine phosphatase LMW-PTP exhibits distinct roles between vascular endothelial and smooth muscle cells.
    Shimizu H; Toyama O; Shiota M; Kim-Mitsuyama S; Miyazaki H
    J Recept Signal Transduct Res; 2005; 25(1):19-33. PubMed ID: 15960392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine suppresses platelet-derived growth factor (PDGF) BB-induced PDGF-beta receptor phosphorylation by protein tyrosine phosphatase-mediated dephosphorylation in vascular smooth muscle cells.
    Yoshimura H; Nariai Y; Terashima M; Mitani T; Tanigawa Y
    Biochim Biophys Acta; 2005 Sep; 1745(3):350-60. PubMed ID: 16112211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
    Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight protein-tyrosine phosphatase tyrosine phosphorylation by c-Src during platelet-derived growth factor-induced mitogenesis correlates with its subcellular targeting.
    Cirri P; Chiarugi P; Taddei L; Raugei G; Camici G; Manao G; Ramponi G
    J Biol Chem; 1998 Dec; 273(49):32522-7. PubMed ID: 9829986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chrysin restores PDGF-induced inhibition on protein tyrosine phosphatase and reduces PDGF signaling in cultured VSMCs.
    Lo HM; Wu MW; Pan SL; Peng CY; Wu PH; Wu WB
    J Nutr Biochem; 2012 Jun; 23(6):667-78. PubMed ID: 21803557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling.
    Chiarugi P; Cirri P; Marra F; Raugei G; Fiaschi T; Camici G; Manao G; Romanelli RG; Ramponi G
    J Biol Chem; 1998 Mar; 273(12):6776-85. PubMed ID: 9506979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration.
    Weber DS; Taniyama Y; Rocic P; Seshiah PN; Dechert MA; Gerthoffer WT; Griendling KK
    Circ Res; 2004 May; 94(9):1219-26. PubMed ID: 15059930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
    Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in the expression of DEP-1 and other PDGF receptor-antagonizing PTPs during onset and termination of neointima formation.
    Kappert K; Paulsson J; Sparwel J; Leppänen O; Hellberg C; Ostman A; Micke P
    FASEB J; 2007 Feb; 21(2):523-34. PubMed ID: 17158785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells.
    Uzui H; Lee JD; Shimizu H; Tsutani H; Ueda T
    Atherosclerosis; 2000 Mar; 149(1):51-9. PubMed ID: 10704614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells.
    Hayashi K; Shibata K; Morita T; Iwasaki K; Watanabe M; Sobue K
    J Biol Chem; 2004 Sep; 279(39):40807-18. PubMed ID: 15272025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
    Pukac L; Huangpu J; Karnovsky MJ
    Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATF-1 mediates protease-activated receptor-1 but not receptor tyrosine kinase-induced DNA synthesis in vascular smooth muscle cells.
    Ghosh SK; Gadiparthi L; Zeng ZZ; Bhanoori M; Tellez C; Bar-Eli M; Rao GN
    J Biol Chem; 2002 Jun; 277(24):21325-31. PubMed ID: 11925444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation.
    Chiarugi P; Cirri P; Taddei L; Giannoni E; Camici G; Manao G; Raugei G; Ramponi G
    J Biol Chem; 2000 Feb; 275(7):4640-6. PubMed ID: 10671492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor BB-induced p38 mitogen-activated protein kinase activation causes cell growth, but not apoptosis, in vascular smooth muscle cells.
    Yamaguchi H; Igarashi M; Hirata A; Susa S; Ohnuma H; Tominaga M; Daimon M; Kato T
    Endocr J; 2001 Aug; 48(4):433-42. PubMed ID: 11603565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II-augmented migration of VSMCs towards PDGF-BB involves Pyk2 and ERK 1/2 activation.
    Blaschke F; Stawowy P; Kappert K; Goetze S; Kintscher U; Wollert-Wulf B; Fleck E; Graf K
    Basic Res Cardiol; 2002 Jul; 97(4):334-42. PubMed ID: 12111044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood lipid mediator sphingosine 1-phosphate potently stimulates platelet-derived growth factor-A and -B chain expression through S1P1-Gi-Ras-MAPK-dependent induction of Kruppel-like factor 5.
    Usui S; Sugimoto N; Takuwa N; Sakagami S; Takata S; Kaneko S; Takuwa Y
    J Biol Chem; 2004 Mar; 279(13):12300-11. PubMed ID: 14711826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.